Wednesday, July 10, 2024

CATEGORY

Alexion

Breakthrough in Paroxysmal Nocturnal Hemoglobinuria Therapy: FDA Greenlights Voydeya by Alexion as Novel Adjunct Treatment

Alexion, in collaboration with AstraZeneca Rare Disease, has made a significant announcement regarding the FDA approval of Voydeya (danicopan) as an adjunct therapy for...

Latest news